Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication

British Journal of Surgery

Volumn 96, Issue 9, 2009, Pages 1023-1030

  Broeders, J A ^a   Draaisma, W A ^a   Bredenoord, A J ^a   De Vries, D R ^a   Rijnhart de Jong, H G ^a   Smout, A J ^a   Gooszen, H G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; ESOPHAGEAL ACID HYPERSENSITIVITY; ESOPHAGUS PH; ESOPHAGUS PRESSURE; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HUMAN; HYPERSENSITIVITY; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MANOMETRY; PH MEASUREMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; REFLUX ESOPHAGITIS; STOMACH FUNDOPLICATION; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AGED, 80 AND OVER; DRUG RESISTANCE; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGITIS, PEPTIC; FEMALE; FUNDOPLICATION; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERSENSITIVITY; MALE; MANOMETRY; MIDDLE AGED; OMEPRAZOLE; PROTON PUMP INHIBITORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 69249127944     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6684     Document Type: Conference Paper

References (50)

1. Howard PJ, Maher L, Pryde A, Heading RC. Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease. Gut 1991; 32: 128-132.
2. Eriksen CA, Cullen PT, Sutton D, Kennedy N, Cuschieri A. Abnormal esophageal transit in patients with typical reflux symptoms but normal endoscopic and pH profiles. Am J Surg 1991; 161: 657-661.
3. Trimble KC, Pryde A, Heading RC. Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 1995; 37: 7-12.
4. Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996; 110: 1982-1996.
5. Clouse RE, Richter JE, Heading RC, Janssens J, Wilson JA. Functional esophageal disorders. Gut 1999; 45(Suppl 2): II31-II36.
6. Shi G, Bruley des Varannes S, Scarpignato C, Le Rhun M, Galmiche JP. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995; 37: 457-464.
7. Wiener GJ, Richter JE, Copper JB, Wu WC, Castell DO. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988; 83: 358-361.
8. Weusten BL, Roelofs JM, Akkermans LM, Van Berge-Henegouwen GP, Smout AJ. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994; 107: 1741-1745.
9. Galmiche JP, Clouse RE, Bálint A, Cook IJ, Kahrilas PJ, Paterson WG et al. Functional esophageal disorders. Gastroenterology 2006; 130: 1459-1465.
10. Bais JE, Bartelsman JF, Bonjer HJ, Cuesta MA, Go PM, Klinkenberg-Knol EC et al. Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group. Lancet 2000; 355: 170-174.
11. Draaisma WA, Ruurda JP, Scheffer RC, Simmermacher RK, Gooszen HG, Rijnhart-de Jong HG et al. Randomized clinical trial of standard laparoscopic versus robot-assisted laparoscopic Nissen fundoplication for gastro-oesophageal reflux disease. Br J Surg 2006; 93: 1351-1359.
12. Draaisma WA, Buskens E, Bais JE, Simmermacher RK, Rijnhart-de Jong HG, Broeders IA et al. Randomized clinical trial and follow-up study of cost-effectiveness of laparoscopic versus conventional Nissen fundoplication. Br J Surg 2006; 93: 690-697.
13. Visick AH. A study of the failures after gastrectomy. Ann R Coll Surg Engl 1948; 3: 266-284.
14. Rijnhart-de Jong HG, Draaisma WA, Smout AJ, Broeders IA, Gooszen HG. The Visick score: a good measure for the overall effect of antireflux surgery? Scand J Gastroenterol 2008; 43: 787-793.
15. de Boer AG, van Lanschot JJ, Stalmeier PF, van Sandick JW, Hulscher JB, de Haes JC et al. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res 2004; 13: 311-320.
16. Nord E. The validity of a visual analogue scale in determining social utility weights for health states. Int J Health Plann Manage 1991; 6: 234-242.
17. Savary M, Miller G. The oesophagus. In Handbook and Atlas of Endoscopy, Savary M, Miller G (eds). Gassman AG: Solothurn, Switzerland, 1978; 135-142.
18. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-180.
19. Jamieson JR, Stein HJ, DeMeester TR, Bonavina L, Schwizer W, Hinder RA et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992; 87: 1102-1111.
20. Richter JE, Bradley LA, DeMeester TR, Wu WC. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992; 37: 849-856.
21. Johnson LF, DeMeester TR. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974; 62: 325-332.
22. Rodriguez-Stanley S, Robinson M, Earnest DL, Greenwood-Van Meerveld B, Miner PB JR. Esophageal hypersensitivity may be a major cause of heartburn. Am J Gastroenterol 1999; 94: 628-631.
23. De Caestecker JS. Twenty-four-hour oesophageal pH monitoring: advances and controversies. Neth J Med 1989; 34(Suppl): S20-S39.
24. Gignoux C, Bonnet-Eymard PO, Hostein J, Fournet J. Enregistrement ambulatoire du pH oesophagien pendant 24 heures dans une population de 27 témoins: analyse des facteurs techniques et méthodologiques influençant les résultats. Gastroenterol Clin Biol 1987; 11: 17-23.
25. Johnsson F, Joelsson B, Isberg PE. Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut 1987; 28: 1145-1150.
26. De Caestecker JS, Blackwell JN, Pryde A, Heading RC. Daytime gastro-oesophageal reflux is important in oesophagitis. Gut 1987; 28: 519-526.
27. Smout AJ, Breedijk M, van der ZC, Akkermans LM. Physiological gastroesophageal reflux and esophageal motor activity studied with a new system for 24-hour recording and automated analysis. Dig Dis Sci 1989; 34: 372-378.
28. Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001; 120: 1599-1606.
29. Bredenoord AJ, Weusten BL, Timmer R, Smout AJ. Characteristics of gastroesophageal reflux in symptomatic patients with and without excessive esophageal acid exposure. Am J Gastroenterol 2006; 101: 2470-2475.
30. Trimble KC, Douglas S, Pryde A, Heading RC. Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux. Dig Dis Sci 1995; 40: 1098-1104.
31. Shi G, Bruley des Valannes S, Scarpignato C, Le Rhun M, Galmiche JP. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995; 37: 457-464.
32. Khajanchee YS, Hong D, Hansen PD, Swanström LL. Outcomes of antireflux surgery in patients with normal preoperative 24-hour pH test results. Am J Surg 2004; 187: 599-603.
33. Pace F, Santalucia F, Bianchi PG. Natural history of gastro-oesophageal reflux disease without oesophagitis. Gut 1991; 32: 845-848.
34. Caviglia R, Ribolsi M, Maggiano N, Gabbrielli AM, Emerenziani S, Guarino MP et al. Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure. Am J Gastroenterol 2005; 100: 543-548.
35. Lynn RB. Mechanisms of esophageal pain. Am J Med 1992; 92: 11S-19S.
36. Tobey NA, Hosseini SS, Argote CM, Dobrucali AM, Awayda MS, Orlando RC. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol 2004; 99: 13-22.
37. de Vries D, Herwaarden MA, Smout AJ, Samsom M. Distinct clinical and epidemiological features separate GERD patients with physiological esophageal acid exposure from patients with pathological acid exposure. Gastroenterology 2008; 134: A720.
38. Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006; 55: 1398-1402.
39. Bredenoord AJ, Draaisma WA, Weusten BL, Gooszen HG, Smout AJ. Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery. Gut 2008; 57: 161-166.
40. Mainie I, Tutuian R, Agrawal A, Adams D, Castell DO. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006; 93: 1483-1487.
41. Campos GM, Peters JH, DeMeester TR, Oberg S, Crookes PF, Tan S et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 1999; 3: 292-300.
42. Thibault R, Coron E, Sébille V, Sacher-Huvelin S, Bruley des Varannes S, Gournay J et al. Antireflux surgery for non-erosive and erosive reflux disease in community practice. Aliment Pharmacol Ther 2006; 24: 621-632.
43. Bell RC, Hanna P, Brubaker S. Laparoscopic fundoplication for symptomatic but physiologic gastroesophageal reflux. J Gastrointest Surg 2001; 5: 462-467.
44. Booth MI, Stratford J, Thompson E, Dehn TC. Laparoscopic antireflux surgery in the treatment of the acid-sensitive oesophagus. Br J Surg 2001; 88: 577-582.
45. del Genio G, Tolone S, del Genio F, Aggarwal R, d'Alessandro A, Allaria A et al. Prospective assessment of patient selection for antireflux surgery by combined multichannel intraluminal impedance pH monitoring. J Gastrointest Surg 2008; 12: 1491-1496.
46. Leeder PC, Watson DI, Jamieson GG. Laparoscopic fundoplication for patients with symptoms but no objective evidence of gastroesophageal reflux. Dis Esophagus 2002; 15: 309-314.
47. Booth MI, Stratford J, Dehn TC. Patient self-assessment of test-day symptoms in 24-h pH-metry for suspected gastroesophageal reflux disease. Scand J Gastroenterol 2001; 36: 795-799.
48. Draaisma WA, Rijnhart-de Jong HG, Broeders IA, Smout AJ, Furnee EJ, Gooszen HG. Five-year subjective and objective results of laparoscopic and conventional Nissen fundoplication: a randomized trial. Ann Surg 2006; 244: 34-41.
49. Huttl TP, Hohle M, Meyer G, Schildberg FW. [Antireflux surgery in Germany. Results of a representative survey with analysis of 2540 antireflux operations.] Chirurg 2002; 73: 451-461.
50. Jamieson GG, Watson DI, Britten-Jones R, Mitchell PC, Anvari M. Laparoscopic Nissen fundoplication. Ann Surg 1994; 220: 137-145.